Cash on Hand for Humana (HUM)
According to Humana's latest reported financial statements, the company's latest reported cash and short-term investments is $4.20B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

HUM
Currently viewingCash on HandSwitch metric
Latest period
$4.20B
YoY change
+89.1%
5Y CAGR
-2.1%
Peak year (2022)
$5.06B
Latest annual
$4.20B
Cash on Hand history chart for Humana (HUM) from 1990 to 2025
Cash on Hand history table for Humana (HUM) from 1990 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $4.20B | +89.1% | ||
| 2024 | $2.22B | -52.7% | ||
| 2023 | $4.69B | -7.3% | ||
| 2022 | $5.06B | +49.1% | ||
| 2021 | $3.39B | -27.4% | ||
| 2020 | $4.67B | +15.3% | ||
| 2019 | $4.05B | +73.0% | ||
| 2018 | $2.34B | -42.0% | ||
| 2017 | $4.04B | +4.3% | ||
| 2016 | $3.88B | +50.8% | ||
| 2015 | $2.57B | +32.9% | ||
| 2014 | $1.94B | +70.0% | ||
| 2013 | $1.14B | -12.9% | ||
| 2012 | $1.31B | -5.2% | ||
| 2011 | $1.38B | -17.7% | ||
| 2010 | $1.67B | +3.7% | ||
| 2009 | $1.61B | -18.1% | ||
| 2008 | $1.97B | -3.4% | ||
| 2007 | $2.04B | +17.2% | ||
| 2006 | $1.74B | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | -100.0% | ||
| 2003 | $2.61B | +22.6% | ||
| 2002 | $2.13B | +4.2% | ||
| 2001 | $2.04B | -1.3% | ||
| 2000 | $2.07B | -16.8% | ||
| 1999 | $2.48B | -0.9% | ||
| 1998 | $2.51B | +17.5% | ||
| 1997 | $2.13B | +34.7% | ||
| 1996 | $1.58B | +18.4% | ||
| 1995 | $1.34B | +51.9% | ||
| 1994 | $881.00M | +136.8% | ||
| 1993 | $372.00M | +1182.8% | ||
| 1992 | $29.00M | -60.8% | ||
| 1991 | $74.00M | -25.6% | ||
| 1990 | $99.50M | — |
Cash on Hand values are taken from Humana's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Humana (HUM) reported cash and short-term investments of $4.20B – surged 89.1% year-over-year.
Across 2020–2025 (5 years), Humana cash and short-term investments produced a CAGR of -2.1% – with a net decline across the window.
Humana cash and short-term investments peaked at $5.06B in 2022; the latest annual figure is $4.20B in 2025 (17.0% below peak).
$5.06B stands as the all-time-high annual cash and short-term investments, posted in 2022, against a low of $0 during 2004.
Humana (HUM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $11.85B.
Humana Cash on Hand by Year
Humana Cash on Hand 2025: $4.20B
Humana cash and short-term investments in 2025 was $4.20B, surged 89.1% from 2024.
Humana Cash on Hand 2024: $2.22B
Humana cash and short-term investments in 2024 was $2.22B, plunged 52.7% below 2023.
Humana Cash on Hand 2023: $4.69B
Humana cash and short-term investments in 2023 was $4.69B, declined 7.3% below 2022.
Humana Cash on Hand 2022: $5.06B
Humana cash and short-term investments in 2022 was $5.06B, surged 49.1% from 2021. This figure represents the highest annual value in the available history.
Humana Cash on Hand 2021: $3.39B
Humana cash and short-term investments in 2021 was $3.39B.
See more financial history for Humana (HUM).
Sector peers — Cash on Hand
Companies in the same sector as Humana, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Humana's cash and short-term investments?
- Latest reported cash and short-term investments for Humana (HUM) is $4.20B (period ending December 31, 2025).
How has Humana cash and short-term investments changed year-over-year?
- Humana (HUM) cash and short-term investments changed +89.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Humana cash and short-term investments?
- Humana (HUM) cash and short-term investments compound annual growth rate is -2.1% over the most recent 5 years available.
When did Humana cash and short-term investments hit its highest annual value?
- Humana cash and short-term investments reached its highest annual value of $5.06B in 2022.
What was Humana cash and short-term investments in 2024?
- Humana (HUM) cash and short-term investments in 2024 was $2.22B.
What was Humana cash and short-term investments in 2025?
- Humana (HUM) cash and short-term investments in 2025 was $4.20B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
HUM Overview
Company profile, financial tools, and key metrics
HUM Revenue Counter
Earns $4,112 every second. See per minute, hour, and day.
HUM Earnings Counter
Earns $37.67 per second net profit. See per minute, hour, and day.
HUM Economic Scale
Exceeds Puerto Rico (US)'s GDP. Compare with world economies.
HUM What If Invested
What if you had invested $1,000? See historical returns from any date.
HUM How It Makes Money
Discover visual breakdown of $129.66B in revenue — where it comes from and where it goes.
HUM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HUM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HUM Daily Price Character
Balanced · 48.4% historical win rate (green days). Streaks & record days.
HUM Buybacks
0.49% TTM buyback yield. Shareholder yield & SBC comparison.
HUM Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
HUM Dividend Profile
Yield: 1.46%. Safety: 3/8. See full history.
HUM Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
HUM Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.